Contact PD/PI: SOKOL, RONALD J COMPONENT: OVERALL PROJECT SUMMARY/ABSTRACT Funded by NIH in 2008 and 2013, the Colorado Clinical and Translational Sciences Institute (CCTSI) at the University of Colorado Denver (CU-D) has taken impressive steps to transform and improve the biomedical; research and training enterprise in the Colorado region and to accelerate and catalyze the translation of discoveries into improved patient care and public health. The CCTSI, a partnership of CU-D, CU Boulder (CU- B), Colorado State University (CSU), six hospitals and 20 community organizations, has established new infrastructure, streamlined processes and expanded existing resources and services for investigators and stakeholders; tripled the number of training and education programs supporting development of a translational workforce; administratively centralized and expanded the breadth of clinical research capacity and expertise; established system-wide informatics capabilities; promoted team science and interdisciplinary research; established an extensive community engagement program and enhanced research across the lifespan; streamlined processes and reduced start-up times for trials; created an academic home for clinical & translational scientists and trainees; and actively engaged in CTSA network activities. Despite these successes, there remain many challenges to accelerating the translational research process locally and nationally. This application maps our path forward to meet these challenges. Through 2018 CTSA funding, we will develop new methods, innovations, expertise, and procedures to: a) achieve a new level of measurable performance in training translational teams, b) improve efficiency and quality of the full spectrum of translational research, c) facilitate multi-site clinical trials, d) engage regional communities and stakeholders as partners, and e) collaborate and disseminate best practices into the national CTSA consortium to accelerate the translation of discoveries into improved health and patient care. We will accomplish these objectives by embracing the following five Overall Strategic Goals: Goal 1: Develop, educate and sustain a diverse translational science workforce to ensure highest research innovation, quality and safety. Goal 2: Create a translational research environment in which team science and collaboration both locally and nationally are facilitated, supported and valued. Goal 3: Engage local and national communities and stakeholders in all phases of the translational research process. Goal 4: Create novel methodologies and resources to support and integrate research in special populations, including children, the elderly, the underserved and those with rare diseases. Goal 5: Further innovate and streamline our processes and enhance our informatics capacity for research start-up, implementation and oversight to promote quality, efficiency, & safety of our research and our active participation in the national CTSA Trial Innovation Network. Special efforts will be made to enhance diversity in our workforce. Our progress will be monitored by our Evaluation Core and we will make mid-course corrections as needed to achieve these goals and ultimately improve the health of our state and the nation. Project Summary/Abstract Page 332 Contact PD/PI: SOKOL, RONALD J COMPONENT: OVERALL NARRATIVE The Colorado Clinical and Translational Sciences Institute (CCTSI) is a collaboration between University of Colorado Denver, University of Colorado Boulder, Colorado State University, 6 hospitals and 20 community organizations aimed at translating discoveries into better public health and patient care. Through a variety of programs, the CCTSI will facilitate the performance of high impact research and the training of the next generation of clinical-translational researchers. Emphasis will be placed on accelerating the pace by which research and clinical trials can be conducted while protecting the safety of research participants in order to bring new effective treatments to patients sooner. Ongoing evaluation of our programs will assure that resources are allocated in a cost-effective manner.

National Institute of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
Linked Specialized Center Cooperative Agreement (UL1)
Project #
Application #
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Cure, Pablo
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Colorado Denver
Other Clinical Sciences
Graduate Schools
United States
Zip Code
Fox, Jacob; Smith, Alexis; Yale, Alexander et al. (2018) Drugs of Abuse and Novel Psychoactive Substances at Outdoor Music Festivals in Colorado. Subst Use Misuse 53:1203-1211
Baschal, Erin E; Terhune, Elizabeth A; Wethey, Cambria I et al. (2018) Idiopathic Scoliosis Families Highlight Actin-Based and Microtubule-Based Cellular Projections and Extracellular Matrix in Disease Etiology. G3 (Bethesda) 8:2663-2672
Saben, Jessica L; Shelton, Shelby K; Hopkinson, Andrew J et al. (2018) The Emergency Medicine Specimen Bank: An Innovative Approach To Biobanking In Acute Care. Acad Emerg Med :
RISE Consortium (2018) Impact of Insulin and Metformin Versus Metformin Alone on ?-Cell Function in Youth With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes. Diabetes Care 41:1717-1725
Gavin, Kathleen M; Kohrt, Wendy M; Klemm, Dwight J et al. (2018) Modulation of Energy Expenditure by Estrogens and Exercise in Women. Exerc Sport Sci Rev 46:232-239
Zhu, Na; Welch, Carrie L; Wang, Jiayao et al. (2018) Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease. Genome Med 10:56
Loi, Michele M; Derderian, S Christopher; Bennett, Tellen D (2018) Tranexamic Acid and Seizures in Pediatric Trauma. Pediatr Crit Care Med 19:1177-1178
Cree-Green, Melanie; Xie, Danielle; Rahat, Haseeb et al. (2018) Oral Glucose Tolerance Test Glucose Peak Time Is Most Predictive of Prediabetes and Hepatic Steatosis in Obese Girls. J Endocr Soc 2:547-562
Libby, Anne M; Ingbar, David H; Nearing, Kathryn A et al. (2018) Developing senior leadership for clinical and translational science. J Clin Transl Sci 2:124-128
Monte, Andrew A; West, Kelsey; McDaniel, Kyle T et al. (2018) CYP2D6 Genotype Phenotype Discordance Due to Drug-Drug Interaction. Clin Pharmacol Ther 104:933-939

Showing the most recent 10 out of 49 publications